Risk assessment in patients with symptomatic and asymptomatic pre-excitation.
Anette JemtrénSerkan SaygiFinn AkerströmFahd AsaadTara BourkeFrieder BraunschweigCarina CarnlöfNikola DrcaPer InsulanderGöran KennebäckAstrid Paul NordinBita SadighAnette RickenlundOtt SaluveerJonas SchwielerEmma SvennbergJari TapanainenYusuf TurkmenHamid BastaniMats Jensen-UrstadPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024)
Sudden loss of pre-excitation during EST has a low NPV in excluding high-risk APs. The EPS with the use of isoproterenol should be considered to accurately assess the risk of patients with pre-excitation regardless of symptoms (ClinicalTrials.gov Identifier: NCT03301935).